|
Company Profiles
The European Association of Cardiothoracic Anaesthesiologists (EACTA) would like to acknowledge our major sponsors, Edwards Lifesciences, Novo Nordisk and Sorin Group, for their much valued support at our recent Annual Meeting which was held in Athens from the 27-29 May 2009. Thank you for helping make EACTA Athens 2009 a great success! EACTA also wishes to thank our exhibitors, who are listed below, for their professional contribution to an informative and educational trade show at the conference. MAJOR SPONSORS
Novo Nordisk launched NovoSeven® in 1996 - a recombinant Factor VIIa enabling coagulation to proceed in the absence of Factors VIII or IX. Specifically, NovoSeven® bypasses the effects of the inhibitors to coagulation and has proven to be effective in the treatment of bleeding in haemophilia patients with inhibitors. Novo Nordisk employs approximately 23,600 full-time employees in 79 countries, and markets its products in 179 countries.
41037 Mirandola Modena Italy Tel. +39 0535 29811 Fax - 39 0535 24312 e-mail: » www.sorin.com Sorin Group is the world leader in the development of high-technology and innovative products for cardiac surgery, cardiovascular, and cardiac rhythm dysfunctions. Sorin Group has over 4000 employees working at facilities in more than 80 countries throughout the world serving over 5000 public and private healthcare centres. Sorin Group offers a complete line of oxygenators and innovative mini-bypass systems, heart lung machines and autotransfusion systems, always moving towards improved safety and biocompatible solutions in CPB: monitoring, materials, circuit optimisation. EXHIBITORS
Focus Medical Hellas S.A. offers services in a wide spectrum of institutions and organisms (Public and Private Hospitals) running all over Greece. The company has developed, installed and applies System of Quality Management, according to the requirements of the standards ELOT EN ISO 9001:2000 and 13485:2003.
Heavy bleeding episodes may occur peri - or post-operatively, for example in cardiac surgery, liver transplant surgery, vascular surgery, obstetrics and especially in trauma. They can be life threatening and always require immediate action. ROTEM® provides a rapid overview about the coagulation status after 10 minutes for implementing and controlling a targeted therapy. At the same time unspecific or ineffective therapies are avoided. In this sense, ROTEM® is not only able to save blood products, treatment costs and time but also saves human lives. ROTEM® is the only system on the market which is transportable in use, can perform four tests at the same time (four channels) and has an automatic precision pipette for ease of use. No additional computer is needed for operation since the system is fully integrated.
Striving for patient safety, we offer a comprehensive range of high-quality products which are less invasive, reduce infections and improve patient comfort. Relying on the most proven technologies and the latest guidelines from Centers for Disease Control, especially Arrow is pioneering with its innovative Maximal Barrier Precautions Kit (CVC), arterial catherization sets and most advanced PSI-systems. Additional Sponsor Acknowledgment: Genesis Pharma |
||||||||||||||||||||||||||||||||||||||||||||||||
Advertisement
MCI Travel Grant
To help doctors, from less strong economic countries, to participate in future EACTA meetings MCI and the Directory Board has decided to offer of to 10 Travel grants.
» Read more
Contacts EACTA 2010
Chairman EACTA 2010Peter Alston
E-mail:
Topics
- Cognitive outcome and CABG surgery: a case of the Emperor’s new clothes?
- Can Computerised perioperative data be used to improve outcome from cardiac surgery?
- Renal failure after neonatal heart surgery; prevention and management
- GUCH (Grown-ups with congenital heart disease)
- Improving outcome from CPB
- Guidelines and cardiopulmonary bypass
- Anaesthesia and cardiopulmonary bypass
- TOE imaging of the right heart with congenital heart disease
- Anatomy of the right heart
- Echocardiographic imaging of right heart function
- Future pro- and anti-coagulants
- Blood transfusion and heart surgery
- Vasopressin in the ICU; friend or foe
- Coronary stent thrombosis in the peri-operative period: prevention and treatment
- TOE for all
- The operation was a success but the patient died; what is a meaningful outcome?
- The UK pneumonectomy outcome study
- How to avoid pneumonectomy: Role of bronchial and vascular sleeve resection
- Anaesthesia for anterior mediastinal masses
- General versus regional anaesthesia for carotid endarterectomy
- Pre-operative risk assessment: biomarkers versus exercise testing